secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001193125-26-042827
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

BD completes spin-off of Biosciences & Diagnostic Solutions business and combination with Waters
--------------------------------------------------------------------------------

- BD completed spin-off of Biosciences & Diagnostic Solutions business and combination with Waters, receiving $4 billion cash.
- BD shareholders received 0.135 Waters shares per BD share, representing 39.2% ownership of combined company.
- BD plans to use $2 billion for share repurchases and $2 billion for debt repayment.
- Claire M. Fraser resigned from BD Board and appointed to Waters Board effective upon closing.
- Transaction valued the spun-off business at $18.8 billion based on Waters closing price on Feb 6, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000119312526042827/0001193125-26-042827-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000119312526042827/d104936d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-042827

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer